Georgia Bio Blog

USDA announces up to $1B in loan guarantees

May 21, 2020

USDA is making $1 billion in loan guarantees available “to help rural businesses meet their working capital needs during the coronavirus pandemic,” the department said Thursday. The guarantees apply to loans disbursed through the Business & Industry CARES Act program. In a Notice of Funding Availability made available Thursday but which has yet to be published in the Federal…

Read More

The Race is On: Why Pfizer May Be The Best Bet to Deliver a Vaccine by the Fall

May 21, 2020

In the middle of March, Pfizer chief Albert Bourla beamed into a WebEx video call with the leaders of the American pharmaceutical giant’s vaccine research and manufacturing groups. The two teams had worked late into the night on a robust development plan for Pfizer’s experimental Covid-19 vaccine and told Bourla that they aimed to make it available…

Read More

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

May 21, 2020

BENGALURU/LONDON (Reuters) – The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work. While not yet proven to be effective against the coronavirus, vaccines are seen…

Read More

CRISPR a tool for conservation, not just gene editing

May 21, 2020

The gene-editing technology CRISPR has been used for a variety of agricultural and public health purposes — from growing disease-resistant crops to, more recently, a diagnostic test for the virus that causes COVID-19. Now a study involving fish that look nearly identical to the endangered Delta smelt finds that CRISPR can be a conservation and…

Read More

A New Entry in the Race for a Coronavirus Vaccine: Hope

May 21, 2020

Scientists are increasingly optimistic that a vaccine can be produced in record time. But getting it manufactured and distributed will pose huge challenges. In a medical research project nearly unrivaled in its ambition and scope, volunteers worldwide are rolling up their sleeves to receive experimental vaccines against the coronavirus — only months after the virus was identified. Companies like…

Read More

Our Favorite Benefits Of Ag Gene Editing

May 21, 2020

You can thank plant breeding for nearly everything you eat. From summer corn to winter squash, so much of what we eat is a result of many generations of breeding. But now, we have the ability to improve our food, not in decades, but in just a few years, through gene editing.  Fundamentally, gene editing…

Read More

Companies are investing in sanitizing PPE, keeping business open and potentially reducing medical waste

May 20, 2020

Reports of shortages of personal protective equipment have tormented coronavirus response teams throughout the outbreak. Major mask makers like 3M have been scrambling to meet the increased need to supply more PPE. 3M says it is accelerating production of the N95 mask to achieve a run rate of 2 billion annually over 12 months. Many…

Read More

Coronavirus ‘does not spread easily’ by touching surfaces or objects, CDC says. But it still ‘may be possible.’

May 20, 2020

The Centers for Disease Control and Prevention has always warned that “it may be possible” to become infected with coronavirus by touching contaminated surfaces or objects. It just “does not spread easily” in that manner, the agency says, nor by animal-to-human contact or vice versa. “COVID-19 is a new disease and we are still learning about how it…

Read More

In the Shadows of America’s Smokestacks, Virus Is One More Deadly Risk

May 19, 2020

This isn’t the first time Vicki Dobbins’s town has been forced to shelter in place. Last year, the Marathon Petroleum refinery that looms over her neighborhood near Detroit emitted a pungent gas, causing nausea and dizziness among neighbors and prompting health officials to warn people to stay inside. When a stay-at-home advisory returned in March,…

Read More